CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A DOI Creative Commons

Dandan Feng,

Jie Gao, Ruiqiong Liu

и другие.

Protein & Cell, Год журнала: 2024, Номер 15(10), С. 744 - 765

Опубликована: Март 13, 2024

Coactivator-associated arginine methyltransferase 1 (CARM1) promotes the development and metastasis of estrogen receptor alpha (ERα)-positive breast cancer. The function CARM1 in triple-negative cancer (TNBC) is still unclear requires further exploration. Here, we report that proliferation, epithelial-mesenchymal transition, stemness TNBC. upregulated multiple cancers its expression correlates with progression. Genome-wide analysis showed recruited by hypoxia-inducible factor-1 subunit (HIF1A) occupy promoters CDK4, Cyclin D1, β-Catenin, HIF1A, MALAT1, SIX1 critically involved cell cycle, HIF-1 signaling pathway, Wnt VEGF thereby modulating proliferation invasion TNBC cells. We demonstrated physically associated directly interacts HIF1A. Moreover, found ellagic acid, an inhibitor CARM1, can suppress inhibiting CDK4 expression. Our research has determined molecular basis carcinogenesis effective natural inhibitor, which may provide new ideas drugs for therapy.

Язык: Английский

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies DOI Creative Commons

Yiwen Li,

Yanfei Liu, Shiwei Liu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Апрель 10, 2023

Abstract Vascular complications of diabetes pose a severe threat to human health. Prevention and treatment protocols based on single vascular complication are no longer suitable for the long-term management patients with diabetes. Diabetic panvascular disease (DPD) is clinical syndrome in which vessels various sizes, including macrovessels microvessels cardiac, cerebral, renal, ophthalmic, peripheral systems diabetes, develop atherosclerosis as common pathology. Pathological manifestations DPDs usually manifest macrovascular atherosclerosis, well microvascular endothelial function impairment, basement membrane thickening, microthrombosis. Cardiac, microangiopathy coexist microangiopathy, while renal retinal predominantly microangiopathic. The following associations exist between DPDs: numerous similar molecular mechanisms, risk-predictive relationships diseases. Aggressive glycemic control combined early comprehensive intervention key prevention treatment. In addition widely recommended metformin, glucagon-like peptide-1 agonist, sodium-glucose cotransporter-2 inhibitors, latest aldose reductase peroxisome proliferator-activated receptor-γ agonizts, glucokinases mitochondrial energy modulators, etc. under active development. proposed obtain more systematic care requires center focusing This would leverage advantages cross-disciplinary approach achieve better integration pathogenesis therapeutic evidence. Such strategy confer benefits promote development DPD discipline.

Язык: Английский

Процитировано

274

Hallmarks of DNA replication stress DOI Creative Commons
Sneha Saxena, Lee Zou

Molecular Cell, Год журнала: 2022, Номер 82(12), С. 2298 - 2314

Опубликована: Июнь 1, 2022

Язык: Английский

Процитировано

229

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms DOI Creative Commons
Dan Huang, W. Lee Kraus

Molecular Cell, Год журнала: 2022, Номер 82(12), С. 2315 - 2334

Опубликована: Март 9, 2022

Язык: Английский

Процитировано

160

Cellular pathways influenced by protein arginine methylation: Implications for cancer DOI Creative Commons
Jian Xu, Stéphane Richard

Molecular Cell, Год журнала: 2021, Номер 81(21), С. 4357 - 4368

Опубликована: Окт. 8, 2021

Язык: Английский

Процитировано

131

Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells DOI Creative Commons

Stephanie Tirman,

Annabel Quinet, Matthew Wood

и другие.

Molecular Cell, Год журнала: 2021, Номер 81(19), С. 4026 - 4040.e8

Опубликована: Окт. 1, 2021

Язык: Английский

Процитировано

131

DNA repair defects in cancer and therapeutic opportunities DOI Open Access

Jessica L. Hopkins,

Li Lan, Lee Zou

и другие.

Genes & Development, Год журнала: 2022, Номер 36(5-6), С. 278 - 293

Опубликована: Март 1, 2022

DNA repair and damage signaling pathways are critical for the maintenance of genomic stability. Defects contribute to tumorigenesis, but also render cancer cells vulnerable reliant on remaining activities. Here, we review major classes defects in cancer, instability that they give rise to, therapeutic strategies exploit resulting vulnerabilities. Furthermore, discuss impacts both targeted therapy immunotherapy, highlight emerging principles targeting therapy.

Язык: Английский

Процитировано

126

ADP-ribosylation from molecular mechanisms to therapeutic implications DOI Creative Commons
Marcin J. Suskiewicz, Evgeniia Prokhorova, J.G.M. Rack

и другие.

Cell, Год журнала: 2023, Номер 186(21), С. 4475 - 4495

Опубликована: Окт. 1, 2023

ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms life. The recent emergence new technologies to study has reshaped our understanding the molecular mechanisms govern establishment, removal, recognition this modification, as well its impact on organismal function. These advances have also revealed intricate involvement human physiology pathology enormous potential their manipulation holds for therapy. In review, we present state-of-the-art findings covering work structural biology, biochemistry, cell clinical aspects ADP-ribosylation.

Язык: Английский

Процитировано

79

APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability DOI Creative Commons
Ajinkya S. Kawale, Xiaojuan Ran, Parasvi S. Patel

и другие.

Science Advances, Год журнала: 2024, Номер 10(3)

Опубликована: Янв. 19, 2024

Mutation signatures associated with apolipoprotein B mRNA editing catalytic polypeptide-like 3A/B (APOBEC3A/B) cytidine deaminases are prevalent across cancers, implying their roles as mutagenic drivers during tumorigenesis and tumor evolution. APOBEC3A (A3A) expression induces DNA replication stress increases the cellular dependency on ataxia telangiectasia Rad3-related (ATR) kinase for survival. Nonetheless, how A3A remains unclear. We show that without slowing forks. find single-stranded (ssDNA) gaps through PrimPol-mediated repriming. A3A-induced ssDNA repaired by multiple pathways involving ATR, RAD51, translesion synthesis. Both ATR inhibition trapping of poly(ADP-ribose) polymerase (PARP) PARP inhibitor impair repair gaps, preferentially killing A3A-expressing cells. When used in combination, inhibitors selectively kill cells synergistically a manner dependent PrimPol-generated gaps. Thus, arises from which confer therapeutic vulnerability to gap-targeted inhibitors.

Язык: Английский

Процитировано

19

Rapid Detection and Signaling of DNA Damage by PARP-1 DOI Creative Commons
Nootan Pandey, Ben E. Black

Trends in Biochemical Sciences, Год журнала: 2021, Номер 46(9), С. 744 - 757

Опубликована: Март 3, 2021

Язык: Английский

Процитировано

89

The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells DOI Open Access
Antoine Simoneau,

Rosalinda Xiong,

Lee Zou

и другие.

Genes & Development, Год журнала: 2021, Номер 35(17-18), С. 1271 - 1289

Опубликована: Авг. 12, 2021

PARP inhibitor (PARPi) is widely used to treat BRCA1/2-deficient tumors, but why PARPi more effective than other DNA-damaging drugs unclear. Here, we show that generates DNA double-strand breaks (DSBs) predominantly in a trans cell cycle manner. During the first S phase after exposure, induces single-stranded (ssDNA) gaps behind replication forks. By trapping on DNA, prevents completion of gap repair until next phase, leading collisions forks with ssDNA and surge DSBs. In second cells are unable suppress origin firing through ATR, resulting continuous synthesis Furthermore, cannot recruit RAD51 collapsed Thus, DSBs progressively gaps, fail slow down over multiple cycles, explaining unique efficacy cells.

Язык: Английский

Процитировано

82